- Home
- VYGR vs GWRS Comparison
VYGR vs GWRS Comparison
Compare VYGR & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- GWRS
- Stock Information
- Founded
- VYGR 2013
- GWRS 2003
- Country
- VYGR United States
- GWRS United States
- Employees
- VYGR N/A
- GWRS N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- GWRS Water Supply
- Sector
- VYGR Health Care
- GWRS Utilities
- Exchange
- VYGR Nasdaq
- GWRS Nasdaq
- Market Cap
- VYGR 342.5M
- GWRS 321.8M
- IPO Year
- VYGR 2015
- GWRS 2010
- Fundamental
- Price
- VYGR $5.22
- GWRS $12.20
- Analyst Decision
- VYGR Strong Buy
- GWRS
- Analyst Count
- VYGR 9
- GWRS 0
- Target Price
- VYGR $15.53
- GWRS N/A
- AVG Volume (30 Days)
- VYGR 361.6K
- GWRS 37.9K
- Earning Date
- VYGR 02-26-2025
- GWRS 03-05-2025
- Dividend Yield
- VYGR N/A
- GWRS 2.46%
- EPS Growth
- VYGR N/A
- GWRS N/A
- EPS
- VYGR 0.47
- GWRS 0.27
- Revenue
- VYGR $163,784,000.00
- GWRS $51,809,000.00
- Revenue This Year
- VYGR N/A
- GWRS $0.79
- Revenue Next Year
- VYGR N/A
- GWRS $4.58
- P/E Ratio
- VYGR $11.19
- GWRS $45.38
- Revenue Growth
- VYGR 3.40
- GWRS 0.10
- 52 Week Low
- VYGR $4.99
- GWRS $11.05
- 52 Week High
- VYGR $10.66
- GWRS $13.98
- Technical
- Relative Strength Index (RSI)
- VYGR 38.79
- GWRS 57.72
- Support Level
- VYGR $4.99
- GWRS $11.05
- Resistance Level
- VYGR $5.45
- GWRS $11.94
- Average True Range (ATR)
- VYGR 0.26
- GWRS 0.26
- MACD
- VYGR -0.05
- GWRS 0.12
- Stochastic Oscillator
- VYGR 17.97
- GWRS 90.55
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operate within the State of Arizona.